Genetic Associations with Age-related Macular Degeneration and Genetic Risk Score in the Epidemiologic Coimbra Eye Study

Authors

  • Claudia Farinha AIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal; Ophthalmology Department, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal; Faculty of Medicine – University of Coimbra (FMUC), Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal; University of Coimbra, Coimbra Institute for Clinical and Biomedical Research, Faculty of Medicine. (iCBR- FMUC), Coimbra, Portugal
  • Patrícia Barreto AIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal
  • Rita Coimbra AIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal
  • Maria Luz Cachulo AIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal; Departamento de Oftalmologia, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal; Faculdade de Medicina – Universidade de Coimbra (FMUC), Centro Académico Clínico de Coimbra (CACC), Coimbra, Portugal
  • Joana Barbosa Melo University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Coimbra, Portugal
  • Carel B. Hoyng Department of Ophthalmology, Radboud Universiteit Donders Institute for Brain Cognition and Behaviour, Nijmegan, Gelderland, Netherlands
  • José Cunha-Vaz AIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal; University of Coimbra, Coimbra Institute for Clinical and Biomedical Research, Faculty of Medicine. (iCBR- FMUC), Coimbra, Portugal; University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Coimbra, Portugal
  • Joaquim Murta Ophthalmology Department, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal; Faculty of Medicine – University of Coimbra (FMUC), Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal; University of Coimbra, Coimbra Institute for Clinical and Biomedical Research, Faculty of Medicine. (iCBR- FMUC), Coimbra, Portugal; University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Coimbra, Portugal
  • Rufino Silva AIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal; Ophthalmology Department, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal; Faculty of Medicine – University of Coimbra (FMUC), Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal; University of Coimbra, Coimbra Institute for Clinical and Biomedical Research, Faculty of Medicine. (iCBR- FMUC), Coimbra, Portugal; University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Coimbra, Portugal

DOI:

https://doi.org/10.48560/rspo.25959

Keywords:

Macular Degeneration/epidemiology, Macular Degeneration/genetics, Polymorphism, Single Nucleotide

Abstract

Introduction: To date several genetic variants are known to play an important role in age-related macular degeneration(AMD). Variations in the genetic pool of different populations impact the disease prevalence, incidence and risk of progression. This report aims to determine the genetic contribution in the development of AMD in a Portuguese population from the Coimbra Eye Study (CES,NCT01298674,NCT02748824), and to determine the genetic risk score(GRS).

Methods: Participants in the CES underwent ophthalmologic examination and imaging in baseline and 6.5-year follow-up visits. AMD staging was performed in a centralized reading center. Two genetic analyses were performed, a case-control analysis and a progression to AMD analysis. Genomic DNA was isolated from blood samples collected in the follow-up visit. Genetic sequencing was performed using the EYERISK assay under the European Eye Epidemiology Consortium (E3). Sixty-nine single nucleotide polymorphisms (SNPs) were genotyped and tested for association under an additive model with presence/absence of AMD in the follow-up visit, and with progression/no progression in the longitudinal analysis. Logistic regression analysis was performed to assess allelic odds ratio at 95% CI for each variant, adjusted for age and sex. GRS were calculated for AMD cases/controls and progressors/non-progressors. 

Results: In case-control analysis samples from 237 patients and 640 controls were included. The SNPs associated to increased risk of AMD were: ARMS2 rs10490924, ARMS2/HTRA1 rs3750846,CFH rs35292876,SLC16A8 rs8135665,TGFBR1 rs1626340. The SNPs with protective effect were: CFH rs10922109, CFH rs1410996,C2/CFB/SKIV2L rs429608,CETP rs5817082,CNN2 rs10422209,CFB rs641153 and RDBP_CFB rs760070. In progression to AMD analysis (630 non-progressors and 137 progressors), identified risk-variants for progression were: ARMS2 rs10490924, ARMS2/HTRA1 rs3750846,CFH rs35292876; and protective variants were C2_CFB_SKIV2L rs429608,CFH rs10922109,CFH rs1410996,CNN2 rs10422209,CFHR5 rs10922153,SYN3/TIMP3 rs5754227,COL10A1 rs3812111. The GRS for AMD cases and controls was 1.12±1.19 and 0.65±1.12 (p<0.001), and for progressors and non-progressors was 1.19±1.18 and 0.67±1.14 (p<0.001).

Conclusion: This is the first genetic study in AMD in a Portuguese population.  Similar variants were found to be associated with the presence and progression to AMD in our epidemiological study, while others were protective. The GRS was significantly different between cases and controls showing its potential when assessing risk. Genetic characterization is important to pursue in different populations to further expand the knowledge of AMD pathophysiology.

Downloads

Download data is not yet available.

References

Colijn JM, Buitendijk GHS, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP, et al. Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future. Ophthalmology. 2017;124:1753–63.

Li JQ, Welchowski T, Schmid M, Mauschitz MM, Holz FG, Finger RP. Prevalence and incidence of age-related macular degeneration in Europe: A systematic review and meta-analysis. Br J Ophthal. 2021;104:1077-84. doi: 10.1136/bjophthalmol-2019-314422

Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106–16. doi: 10.1016/S2214-109X(13)70145-1.

Fritsche LG, Chen W, Schu M, Yaspan BL, Yu Y, Thorleifsson G, et al. Seven new loci associated with age-related macular degeneration. Nat Genet. 2013;45:433–9. doi: 10.1038/ng.2578.

Fritsche LG, Igl W, Bailey JN, Grassmann F, Sengupta S, Bragg-Gresham JL, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genets. 2016;48:134–43. doi: 10.1038/ng.3448.

Geerlings MJ, de Jong EK, den Hollander AI. The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment. Mol Immunol. 2017;84:65–76. doi: 10.1016/j.molimm.2016.11.016.

Jordan-Yu JM, Teo K, Fan Q, Gana JC, Leopando AK, Nunes S, et al. T and genetic variations between Asian and Caucasian polypoidal choroidal vasculopathy. Br J Ophthalmol. 2021;105:1716-23. doi: 10.1136/bjophthalmol-2020-317537.

de Breuk A, Acar IE, Kersten E, Schijvenaars MMVAP, Colijn JM, Haer-Wigman L, et al. Development of a Genotype Assay for Age-Related Macular Degeneration: The EYE-RISK Consortium. Ophthalmology. 2020 ;128:1604-17. doi: 10.1016/j.ophtha.2020.07.037

Gibson G. Rare and common variants: Twenty arguments. Nat Rev Genet. 2012;13:135–45.

Cooke Bailey J, Hoffman J, Sardell R, Scott W, Pericak-Vance M, Haines J. The Application of Genetic Risk Scores in Age-Related Macular Degeneration: A Review. J Clin Med. 2016;5:31. doi: 10.3390/jcm5030031.

Wang JJ, Buitendijk GHS, Rochtchina E, Lee KE, Klein BEK, Van Duijn CM, et al. Genetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populations. Ophthalmology. 2014;121:667–75. doi: 10.1016/j.ophtha.2013.10.017.

Lambert NG, ElShelmani H, Singh MK, Mansergh FC, Wride MA, Padilla M, et al. Prog Retin Eye Res. 2016;54:64-102.

Colijn JM, Meester-Smoor M, Verzijden T, de Breuk A, Silva R, Merle BMJ, et al. Genetic Risk, Lifestyle, and Age-Related Macular Degeneration in Europe: The EYE-RISK Consortium. Ophthalmology. 2021;128:1039-49. doi: 10.1016/j.ophtha.2020.11.024.

Cachulo MDL, Lobo C, Figueira J, Ribeiro L, Laíns I, Vieira A, et al. Prevalence of age-related macular degeneration in Portugal: The Coimbra eye study - Report 1. Ophthalmologica. 2015;233:119–27. doi: 10.1159/000371584.

Cachulo M da L, Laíns I, Lobo C, Figueira J, Ribeiro L, Marques JP, et al. Age-related macular degeneration in Portugal: prevalence and risk factors in a coastal and an inland town. The Coimbra Eye Study – Report 2. Acta Ophthalmol. 2016;94:e442-53. doi: 10.1111/aos.12950.

Farinha CVL, Cachulo ML, Alves D, Pires I, Marques JP, Barreto P, et al. Incidence of age-related macular degeneration in the central region of Portugal: The coimbra eye study-report 5. Ophthalmic Res. 2019;61:226-35. doi: 10.1159/000496393.

Farinha C, Cachulo ML, Coimbra R, Alves D, Nunes S, Pires I, et al. Age-Related Macular Degeneration Staging by Color Fundus Photography vs. Multimodal Imaging—Epidemiological Implications (The Coimbra Eye Study—Report 6). J Clin Med. 2020;9:1329. doi: 10.3390/jcm9051329.

Raimundo M, Mira F, Cachulo ML, Barreto P, Ribeiro L, Farinha C, et al. Adherence to a Mediterranean diet, lifestyle and age-related macular degeneration: the Coimbra Eye Study - report 3. Acta Ophthalmol. 2018;96:e926-32. doi: 10.1111/aos.13775.

Nunes S, Alves D, Barreto P, Raimundo M, da Luz Cachulo M, Farinha C, et al. Adherence to a mediterranean diet and its association with age-related macular degeneration. The Coimbra Eye Study–Report 4. Nutrition. 2018;51–52:6–12. doi: 10.1016/j.nut.2017.12.010.

Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CFL, et al. The Prevalence of Age-related Maculopathy in the Rotterdam Study. Ophthalmology. 1995;102:205–10.

Klaver CC, Assink JJ, van Leeuwen R, Wolfs RC, Vingerling JR, Stijnen T, et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2001;42:2237-41.

Geerlings MJ, Kersten E, Groenewoud JMM, Fritsche LG, Hoyng CB, de Jong EK, et al. Geographic distribution of rare variants associated with age-related macular degeneration. Mol Vis. 2018;24:75–82.

Lorés-Motta L, van Beek AE, Willems E, Zandstra J, van Mierlo G, Einhaus A, et al. Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration. Am J Hum Genet. 2021;108:1367-84. doi: 10.1016/j.ajhg.2021.06.002.

de Jong S, Gagliardi G, Garanto A, de Breuk A, Lechanteur YTE, Katti S, et al. Implications of genetic variation in the complement system in age-related macular degeneration. Prog Retin Eye Res. 2021;84:100952. doi: 10.1016/j.preteyeres.2021.100952.

Cabral de Guimaraes TA, Daich Varela M, Georgiou M, Michaelides M. Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions. Br J Ophthalmol. 2021(in press). doi: 10.1136/bjophthalmol-2020-318452.

Downloads

Published

2022-04-10

How to Cite

Farinha, C., Barreto, P. ., Coimbra, R. ., Cachulo, M. L. . ., Melo, J. B. ., Hoyng, C. B. ., Cunha-Vaz , J. ., Murta, J., & Silva, R. (2022). Genetic Associations with Age-related Macular Degeneration and Genetic Risk Score in the Epidemiologic Coimbra Eye Study. Revista Sociedade Portuguesa De Oftalmologia, 46(1), 33–42. https://doi.org/10.48560/rspo.25959

Issue

Vol. 46 No. 1 (2022)

Section

Original Article

License

Copyright (c) 2022 Revista Sociedade Portuguesa de Oftalmologia

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Do not forget to download the Authorship responsibility statement/Authorization for Publication and Conflict of Interest.
The article can only be submitted with these two documents.
To obtain the Authorship responsibility statement/Authorization for Publication file, click here.

To obtain the Conflict of Interest file (ICMJE template), click here